Preg and HTN Lecture

  • Upload
    nohazz

  • View
    229

  • Download
    0

Embed Size (px)

Citation preview

  • 8/13/2019 Preg and HTN Lecture

    1/27

    PREGNANCYAND

    HYPERTENSION

    DR MOHAMMED ALMOGAHED

    M.D

  • 8/13/2019 Preg and HTN Lecture

    2/27

    REMEMBER THAT

    A HEALTHY FETUS DEPENDS ON

    A HEALTHY MOTHER

  • 8/13/2019 Preg and HTN Lecture

    3/27

    Hypertension is a common medicalproblem during pregnancy, with a

    prevalence of 6 to 8%. It isdiagnosed when blood pressure isgreater than 140/90 mm Hgmeasured with the patient in thesitting position on two occasions

  • 8/13/2019 Preg and HTN Lecture

    4/27

    During a normal pregnancy, bloodpressure declines during the first

    and second trimesters and risesto prepregnancy levels near term

  • 8/13/2019 Preg and HTN Lecture

    5/27

    Hypertension during pregnancy can beclassified as

    1- chronic hypertension(prepregnancy HTN)2-preeclampsia

    3-gestational hypertension or nonproteinuric

    hypertension of pregnancy4- chronic hypertension plus preeclampsia

    5-antenatal unclassifiable hypertension

  • 8/13/2019 Preg and HTN Lecture

    6/27

    Chronic hypertention

    Present in 1 to 5% of pregnant

    women.most cases are due toessential HTN.for the Unusualindividual with secondry HTN

    (CTD,aortic coarctation,intrinsicrenal disease,renal artery stenosis,and cushings disease)

  • 8/13/2019 Preg and HTN Lecture

    7/27

    gestational hypertension(GH)

    Is hypertension that develops any timeduring pregnanacy without protein in urine

    (nonproteinuric HTN of pregnancy)

    (GH)resolves by 3 months postpartum,and

    HTN often normalizes within 2 weeks ofdelivery

  • 8/13/2019 Preg and HTN Lecture

    8/27

    Preeclampsia

    Can occur any time after 20weeks of gestation and up to 6weeks postpartum

  • 8/13/2019 Preg and HTN Lecture

    9/27

    TREATMENT

  • 8/13/2019 Preg and HTN Lecture

    10/27

    Chronic hypertensinWomen with preexisting HTN the usual

    Blood pressure decrease during theFirst trimester often allows discontinuti

    On of antihypertensive drugs.BP

    Can be monitored and medications

    Reinstituted if needed

  • 8/13/2019 Preg and HTN Lecture

    11/27

    Chronic HTN newly diagnosed during

    Pregnancy can be differentiated from

    Transient gestational HTN in that theFormer persists more than 3 months

    postpartum

  • 8/13/2019 Preg and HTN Lecture

    12/27

    European heart association guidline 2011

    1-SBP 140-150mmHg

    DBP 90-99 mmHgNon pharmacological management

    2-SBP >170 mmHgEmergency hospitalisation

    Pre-eclampsia associated with pulmonary oedema

    Infusion i/v nitroglycerene

  • 8/13/2019 Preg and HTN Lecture

    13/27

    3-In severe HTN

    drug treatment with i/v labetolol

    Or methyldopa or nifidepine tablet

  • 8/13/2019 Preg and HTN Lecture

    14/27

    4-With continued pre-pregnancy HTN

    Pre-pregnancy medication to be continued

    (angiotensin converting enzyme-ACE-andAngiotensin receptor blockers-ARB-and

    Direct renin inhibitors are strictly

    contraindicated

  • 8/13/2019 Preg and HTN Lecture

    15/27

    5-For delivery(in gestational HTN) with

    Proteinuria with adverse condition

    induction

  • 8/13/2019 Preg and HTN Lecture

    16/27

    Gestational HTN

    Transient gestational HTN is treated with

    Bed rest,close monitoring of the mother andfetus.when to initiate antihypertensive drugs

    Is controversial.many authorities

    Recommend drug therapy when the bloodPressure exceeds 140/90 mmhg

  • 8/13/2019 Preg and HTN Lecture

    17/27

    METHYLDOPA(CENTRAL SYMPATHOLYTIC)

    Reduces vascular resistance while preserv-

    Ing maternal cardiac output and uteroplacental perfusion.considered safe to use when

    Breastfeeding

    Dose 250mg 2-3times/day can be asNeeded (maximum dose 3g)DOSAGE FORMS(tablet 125Mg-250Mg-500Mg)ingection 50Mg/ML

  • 8/13/2019 Preg and HTN Lecture

    18/27

    CLONIDINE (CENTRAL SYMPATHOLYTIC)

    Dose 0.1mg 1-2 times/day

    Onset of action:oral 0.5-1hourDuration:6-10 hours

    (do not discontinue clonidineabruptly

    because risk of rebound HTN.if needdecrease gradually)

    DOSAGE FORMS(TABLET 0.1Mg-0.2Mg-0.3mg)ingection 100mcg/ml

  • 8/13/2019 Preg and HTN Lecture

    19/27

    LABETALOL(ALPHA AND BETA BLOCKERS)

    Used in several trials without adverse effects

    -blocking results in vasodilation includingUteroplacental blood vessels.and-blockade

    Prevents reflex tachycardia.cardiac output is

    Unchanged.low concentration in breast milk

  • 8/13/2019 Preg and HTN Lecture

    20/27

    LABETALOL(ALPHA AND BETA BLOCKERS)

    Dose100mg twice daily,may increase as

    Needed every 2-3days by 100mg untilDesired response is obtained(maximum 2g)

    Onset of action:oral:20 min-2hours.

    i/v 2-5 minDOSAGE FORMS(TABLET 100Mg-200Mg-300mg) ingection 5mg/ml

  • 8/13/2019 Preg and HTN Lecture

    21/27

    -blockers

    Probably safe for third-trimester use,but

    Neonatal bradycardia,respiratory distress,

    And hypoglycemia have been reported.Use earlier in gestation may result in intra-

    Uterine grouth retardation.atenololand meto

    Prolol are concentrated in breast milk

    Propranololhas low concentrated in breast

    milk

  • 8/13/2019 Preg and HTN Lecture

    22/27

    Atenololtablet 25-100mg 1-2/day

    Metoprololtablet 50-100mg 1-2/day

    Pindololtablet 5-10mg twice/day as

    Necessary every3-4 weeks maximum dose

    60mg

    Propranololtablet 20-40mg twice dailydose

    As necessary every3-7days

    Maximum dose

  • 8/13/2019 Preg and HTN Lecture

    23/27

    Hydralazine(direct arterial vasodilator)

    Extensively used during pregnancy.it causes

    Vascular dilation and reflex tachycardia

    Primarily used parenterallay for acute mana-

    Gement of HTN or with methyldopa or

    -blocking agent

    Dose10-20mg i/v every4-6h,change to oral

    Therapy as soon as possible(max.dose 250mg)DOSAGE FORMS(TABLET 10Mg-25Mg-50Mg-100Mg)ingection 20mg/ml

  • 8/13/2019 Preg and HTN Lecture

    24/27

    NIFEDIPINE(calcium-channel blockers)

    Probably safely used in the third trimester

    Their use maintains uteroplacental perfusion

    May also have tocolytic effect.S/L associatedWith hypotension and fetal distress.avoid use

    With magnesium sulfate because combination

    Risks profound hypotension

    Dose10-30mg 3 times/day(capsules)

    30-60mg once daily as sustained release tablet

  • 8/13/2019 Preg and HTN Lecture

    25/27

  • 8/13/2019 Preg and HTN Lecture

    26/27

    Angiotensin-converting enzymeinhibitors

    And angiotensin receptor blockers

    Contraindication.it affects renal development

    In the second and third trimesters.miscarriage

    Fetal death,malformations, and neonatal renalFailure can be result.

  • 8/13/2019 Preg and HTN Lecture

    27/27

    THANK

    YOU